Entrar/Registro  
HOME SPANISH
 
Revista Médica MD
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Médica MD >Year 2017, Issue 2


Piccoli GB, Alrukhaimi M, Liu, Zhi-Hong, Zakharova E, Levin A
What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman's Day
Rev Med MD 2017; 8.9 (2)

Language: Inglés
References: 114
Page: 121-129
PDF: 3226.79 Kb.


Full text




ABSTRACT

Chronic Kidney Disease affects approximately 10% of the world's adult population: it is within the top 20 causes of death worldwide, and its impact on patients and their families can be devastating. World Kidney Day and International Women's Day in 2018 coincide, thus offering an opportunity to reflect on the importance of women's health and specifically their kidney health, on the community, and the next generations, as well as to strive to be more curious about the unique aspects of kidney disease in women so that we may apply those learnings more broadly.
Girls and women, who make up approximately 50% of the world's population, are important contributors to society and their families. Gender differences continue to exist around the world in access to education, medical care, and participation in clinical studies. Pregnancy is a unique state for women, offering an opportunity for diagnosis of kidney disease, but also a state where acute and chronic kidney diseases may manifest, and which may impact future generations with respect to kidney health. There are various autoimmune and other conditions that are more likely to impact women with profound consequences for child bearing, and on the fetus. Women have different complications on dialysis than men, and are more likely to be donors than recipients of kidney transplants.
In this editorial, we focus on what we do and do not know about women, kidney health, and kidney disease, and what we might learn in the future to improve outcomes worldwide.


Key words: women, access to care, kidney health, acute and chronic kidney disease, inequities.


REFERENCIAS

  1. 1.-Boyd K, Korf B, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 2009;61(1): 1–16.

  2. 2.-Hegedus B, Yeh T, Lee D, Emnett J, Li J, Gutmann D. Neurofibromin regulates somatic growth through the hypothalamic–pituitary axis. Human Molecular Genetics 2008;17(19):2956-2966.

  3. 3.-Trovó A, Goloni-Bertollo E, Mancini U, Rahal P, de Azevedo Jr W, Tajara E. Genetics and Molecular Biology 2004; 27(3);6-330.

  4. 4.-Ramirez-Garcia SA, Flores-Alvarado LJ, Topete- González LR, Charles-Niño C, Mazariegos-Rubi M, Dávalos-Rodríguez NO. High frequency of ancestral allele of the TJP1 polymorphism rs2291166 in Mexican population, conformational effect and applications in surgery and medicine.Cir Cir. 2016;84(1):28-36.






>Journals >Revista Médica MD >Year 2017, Issue 2
 

· Journal Index 
· Links 






       
Copyright 2019